EUVIMEDEUVIMED entdecken
Crossref

Thermodynamic Insights into the WT and Y220C TP53 DBDs Reveal that the Oncogenic Y220C Variant is a Loss-of-Function Mutation for Zn2+-Binding at Physiological Temperature

Jacob I Stuckey iD, Valerie Vivat, Bradley M Dickson iD, Jeremy W Setser, Yong Li, Claudia M Cremers, Jonathan E Wilson, Daniele Peterle, John R Engen, Thomas E Wales, Rainer Wilcken iD, Erin B Rohan und 3 weitere

Biochemistry · 2026

DOI: 10.1021/acs.biochem.6c00068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry, 2026. Verfasst von Jacob I Stuckey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Flare Therapeutics, Cambridge, Massachusetts02139, United States. Hauptthemen laut MEDLINE: Zinc, Tumor Suppressor Protein p53. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Flare Therapeutics, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present evidence of previously unrecognized allosteric connectivity across the TP53 DNA-binding domain (DBD). Specifically, we have found evidence of an explicit influence on the Zn2+-binding site from the region surrounding the hotspot Y220C mutation. This allosteric connectivity is intertwined with a temperature-dependent destabilization of Zn2+ binding in both the WT and the Y220C DBDs. Our studies indicate that the Y220C mutation exacerbates this temperature-dependent destabilization of Zn2+ binding to result in overall destabilization of the Y220C variant. We provide detailed thermodynamic evidence that Rezatapopt, a small molecule reactivator of the Y220C DBD, engages Y220C through two thermodynamically distinct binding mechanisms and restores WT-level Zn2+-affinity to this oncogenic variant. A series of thermodynamic models describing the WT and Y220C conformational landscapes as well as the Rezatapopt binding mechanisms are proposed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZincTumor Suppressor Protein p53ThermodynamicsTemperatureBinding SitesHumansProtein DomainsProtein BindingMutationModels, Molecular

Substanzen

ZincTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Flare Therapeutics, Cambridge, Massachusetts02139, United States.
  • Van Andel Institute, Grand Rapids, Michigan49503, United States.
  • Department of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts02115, United States.

ORCID-Profile: Jacob I Stuckey, Bradley M Dickson, Rainer Wilcken, James E Audia

Förderung

  • Flare Therapeutics, Inc.

Zitieren

APA

Stuckey, J. I., Vivat, V., Dickson, B. M., Setser, J. W., Li, Y., Cremers, C. M., Wilson, J. E., Peterle, D., Engen, J. R., Wales, T. E., Wilcken, R., Rohan, E. B., Chenail, G., Audia, J. E., & Sims Iii, R. J. (2026). Thermodynamic Insights into the WT and Y220C TP53 DBDs Reveal that the Oncogenic Y220C Variant is a Loss-of-Function Mutation for Zn2+-Binding at Physiological Temperature. Biochemistry. https://doi.org/10.1021/acs.biochem.6c00068

Vancouver

Stuckey JI, Vivat V, Dickson BM, Setser JW, Li Y, Cremers CM, et al. Thermodynamic Insights into the WT and Y220C TP53 DBDs Reveal that the Oncogenic Y220C Variant is a Loss-of-Function Mutation for Zn2+-Binding at Physiological Temperature. Biochemistry. 2026. doi:10.1021/acs.biochem.6c00068

BibTeX
@article{Stuckey2026,
  author = {Stuckey, Jacob I and Vivat, Valerie and Dickson, Bradley M and Setser, Jeremy W and Li, Yong and Cremers, Claudia M and Wilson, Jonathan E and Peterle, Daniele and Engen, John R and Wales, Thomas E and Wilcken, Rainer and Rohan, Erin B and Chenail, Gregg and Audia, James E and Sims Iii, Robert J},
  title = {Thermodynamic Insights into the WT and Y220C TP53 DBDs Reveal that the Oncogenic Y220C Variant is a Loss-of-Function Mutation for Zn2+-Binding at Physiological Temperature},
  journal = {Biochemistry},
  year = {2026},
  doi = {10.1021/acs.biochem.6c00068}
}
Kostenlos starten →